Literature DB >> 16636048

Stat3 cleavage by caspases: impact on full-length Stat3 expression, fragment formation, and transcriptional activity.

James W Darnowski1, Frederick A Goulette, Ying-jie Guan, Devasis Chatterjee, Zhong-Fa Yang, Leslie P Cousens, Y Eugene Chin.   

Abstract

Stat3 and its isoforms belong to a family of cytoplasmic transcription factors that affect the synthesis of various proteins. Caspases are cysteinyl-aspartate proteases that function under apoptotic and non-apoptotic conditions. We now report that, in addition to transcriptional splicing, Stat3 fragmentation can be mediated by caspases. Caspase activation in DU145 cells was achieved by staurosporine (STS) exposure, and Western analysis revealed a reduction in full-length Stat3 (fl-Stat3) expression that was caspase-mediated. This proteolytic relationship was further studied by exposing purified Stat3 protein to a mixture of active caspases under cell-free conditions. This demonstrated that caspases directly cleaved Stat3 and Stat3 cleavage was accompanied by the apparent formation of cleavage fragment(s). Stat3 cleavage fragments, reflecting multiple caspase cleavage sites, also were observed in vitro following STS exposure in DU145 cells and in HEK293T cells transfected to express Stat3 truncation mutants. The impact of cleavage on Stat3 transcriptional activity next was assessed and revealed that cleavage of fl-Stat3 was accompanied by reductions in Stat3-DNA binding, Stat3-driven reporter protein (luciferase) activity, and the expression of selected Stat3-dependent genes. Further, reduced Stat3 expression correlated with increased sensitivity to apoptotic stimuli. In concomitant experiments, reporter activity was assessed in Stat3 truncation mutant-expressing HEK293T cells and revealed that, under non-apoptotic conditions, expression of different Stat3 fragments induced differential effects on Stat3-driven luciferase activity. These findings demonstrate that fl-Stat3 undergoes proteolytic processing by caspases that reduces its expression and leads to the formation of cleavage fragments that may modulate Stat3 transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16636048     DOI: 10.1074/jbc.M600088200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival.

Authors:  E A Afanasyeva; P Mestdagh; C Kumps; J Vandesompele; V Ehemann; J Theissen; M Fischer; M Zapatka; B Brors; L Savelyeva; V Sagulenko; F Speleman; M Schwab; F Westermann
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

2.  Molecular cloning and expression analysis of the STAT1 gene in the water buffalo (Bubalus bubalis).

Authors:  Tingxian Deng; Chunying Pang; Peng Zhu; Biyun Liao; Ming Zhang; Bingzhuang Yang; Xianwei Liang
Journal:  Trop Anim Health Prod       Date:  2014-10-22       Impact factor: 1.559

3.  Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.

Authors:  Jason K H Lee; Joel D Pearson; Brandon E Maser; Robert J Ingham
Journal:  J Biol Chem       Date:  2013-06-09       Impact factor: 5.157

4.  Stress-induced dynamic regulation of mitochondrial STAT3 and its association with cyclophilin D reduce mitochondrial ROS production.

Authors:  Jeremy A Meier; Moonjung Hyun; Marc Cantwell; Ali Raza; Claudia Mertens; Vidisha Raje; Jennifer Sisler; Erin Tracy; Sylvia Torres-Odio; Suzana Gispert; Peter E Shaw; Heinz Baumann; Dipankar Bandyopadhyay; Kazuaki Takabe; Andrew C Larner
Journal:  Sci Signal       Date:  2017-03-28       Impact factor: 8.192

5.  XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer.

Authors:  Yan Cheng; Michael P Holloway; Kevin Nguyen; Dilara McCauley; Yosef Landesman; Michael G Kauffman; Sharon Shacham; Rachel A Altura
Journal:  Mol Cancer Ther       Date:  2014-01-15       Impact factor: 6.261

6.  Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders.

Authors:  Elizabeth O Hexner; Cynthia Serdikoff; Mahfuza Jan; Cezary R Swider; Candy Robinson; Shi Yang; Thelma Angeles; Stephen G Emerson; Martin Carroll; Bruce Ruggeri; Pawel Dobrzanski
Journal:  Blood       Date:  2007-11-05       Impact factor: 22.113

7.  Caspase 6 regulates B cell activation and differentiation into plasma cells.

Authors:  Chie Watanabe; Geraldine L Shu; Timothy S Zheng; Richard A Flavell; Edward A Clark
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  A phenotypic small-molecule screen identifies an orphan ligand-receptor pair that regulates neural stem cell differentiation.

Authors:  Jonathan P Saxe; Hao Wu; Theresa K Kelly; Michael E Phelps; Yi E Sun; Harley I Kornblum; Jing Huang
Journal:  Chem Biol       Date:  2007-09

Review 9.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

10.  Analysis of changes in the proteome of HL-60 promyeloid leukemia cells induced by the proteasome inhibitor PSI.

Authors:  Mi-Ran Choi; Farhad Najafi; Ahmad R Safa; Hannes C A Drexler
Journal:  Biochem Pharmacol       Date:  2008-04-07       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.